Abstract
Randomized trials targeting cannabis use disorders in patients with psychosis have generally been unsuccessful. One of the largest such trials was the CapOpus trial, which had an impact on the number of monthly joints used, but not on the number of days with cannabis use or positive or negative symptoms.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Schizophrenia Research |
Vol/bind | 151 |
Udgave nummer | 1-3 |
Sider (fra-til) | 191-6 |
Antal sider | 6 |
ISSN | 0920-9964 |
DOI | |
Status | Udgivet - dec. 2013 |